Virtu Financial LLC Opgen Inc Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.32 - $0.79 $22,050 - $54,437	-68,908 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$0.72 - $1.11 $10,309 - $15,894	-14,319 Reduced 17.2%	68,908 $52,000
Q4 2021 Feb 17, 2022	BUY	$1.0 - $2.94 $55,946 - $164,481	55,946 Added 205.07%	83,227 $83,000
Q3 2021 Nov 12, 2021	BUY	$2.18 - $3.58 $14,335 - $23,542	6,576 Added 31.76%	27,281 $79,000
Q2 2021 Sep 17, 2021	SELL	$1.95 - $2.8 $37,385 - $53,681	-19,172 Reduced 48.08%	20,705 $47,000
Q1 2021 May 19, 2021	BUY	$1.8 - $3.55 $71,778 - $141,563	39,877 New	39,877 $100,000
Q2 2020 Aug 07, 2020	SELL	$1.88 - $2.59 $100,204 - $138,047	-53,300 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$1.02 - $7.18 $54,366 - $382,694	53,300 New	53,300 $60,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.